Profile
| Metric | Value |
|---|---|
| Full Name | Opthea Limited |
| Ticker | NASDAQ: OPT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Australia |
| IPO | |
| Indexes | Not included |
| Website | opthea.com |
| Employees | 33 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| Market Cap | - | |
| - | ||
| PE Ratio | - | |
| Beta | N/A | - |
| Revenue | $25K | |
| Revenue, 1Y Change | -80.02% | |
| EPS | -$1.06 | |
| EPS, 1Y Change | +61.69% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 5:8 | |
| Next Split | N/A | N/A |
| Last Ticker Change | CKDXY | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.06 | |
| EPS Estimate | N/A | -$0.16 |
| EPS Est. Change | N/A | +85.40% |
| Revenue | $25.00K | |
| Revenue Estimate | N/A | $636.50K |
| Revenue Est. Change | N/A | +2,446.00% |
| Current Price | - | |
| Price Target | - | $1.00 |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.47 | -$1.06 | +27.78% | |
| -$1.85 | N/A | -74.27% | |
| -$0.16 | N/A | +85.40% | |
| -$0.12 | N/A | +88.70% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $317.75K | $25.00K | -92.13% | |
| $69.54M | N/A | +278,060.00% | |
| $636.50K | N/A | +2,446.00% | |
| $1.63M | N/A | +6,429.00% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | - | |
| Price, 3Y | - | |
| Market Cap, 1Y | - | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | -80.02% | |
| Revenue, 3Y | -72.35% | |
| EPS, 1Y | +61.69% | |
| EPS, 3Y | +41.91% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | - | |
| SMA 200 | N/A | - |
| SMA 200 vs Price | N/A | - |
| SMA 50 | N/A | - |
| SMA 50 vs Price | N/A | - |
| Beta | N/A | - |
| ATR | N/A | - |
| 14-Day RSI | N/A | - |
| 10-Day Volatility | N/A | - |
| 1-Year Volatility | N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $25.00K | |
| EPS | -$1.06 | |
| Gross Profit | -$65.90K | |
| Gross Margin | -263.60% | |
| Operating Profit | -$155.62M | |
| Operating Margin | -622.47% | |
| Net Income | -$162.51M | |
| Net Margin | -650.06% | |
| EBITDA | -$155.53M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | -1.23 | |
| 0.22 | ||
| 0.22 | ||
| - | ||
| - | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | -$201.07M | |
| $48.44M | ||
| $56.80M | ||
| $56.80M | ||
| $257.87M | ||
| $257.87M | ||
| Total Debt | $246.99M | |
| $246.99M | ||
| $9.74M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $162.54M | ||
| $155.62M | ||
| $90.80K | ||
| $0.00 | ||
| $90.80K | ||
| $0.00 | ||
| -$6.94M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$158.37M | ||
| -$13.00K | ||
| $34.71M | ||
| Capex | $13.00K | |
| -$158.39M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Leerink Partners | → | |
| Jefferies | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| EF Hutton | → | |
| EF Hutton |
Analyst sentiment
Institutional ownership
Screeners with OPT
Data Sources & References
- OPT Official Website opthea.com
- OPT Profile on Yahoo Finance finance.yahoo.com/quote/OPT
- OPT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/opt
FAQ
What is the ticker symbol for Opthea Limited?
The ticker symbol for Opthea Limited is NASDAQ:OPT
Does Opthea Limited pay dividends?
No, Opthea Limited does not pay dividends
What sector is Opthea Limited in?
Opthea Limited is in the Healthcare sector
What industry is Opthea Limited in?
Opthea Limited is in the Biotechnology industry
What country is Opthea Limited based in?
Opthea Limited is headquartered in Australia
When did Opthea Limited go public?
Opthea Limited initial public offering (IPO) was on October 16, 2020
Is Opthea Limited in the S&P 500?
No, Opthea Limited is not included in the S&P 500 index
Is Opthea Limited in the NASDAQ 100?
No, Opthea Limited is not included in the NASDAQ 100 index
Is Opthea Limited in the Dow Jones?
No, Opthea Limited is not included in the Dow Jones index
When was Opthea Limited last earnings report?
Opthea Limited's most recent earnings report was on August 29, 2025
When does Opthea Limited report earnings?
The next expected earnings date for Opthea Limited is February 26, 2026